The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections. Journal of Clinical & Experimental Pathology covers all areas of clinical and experimental pathology. Articles such as research papers, review articles, commentaries and short communications leading to the development of Journal of clinical and experimental pathology.

Serology is the scientific study of serum and other body fluids. In practice, the term usually refers to the diagnostic identification of antibodies in the serum. Such antibodies are typically formed in response to an infection against other foreign proteins, or to one's own proteins.  Serologic tests are blood tests that look for antibodies in your blood. They can involve a number of laboratory techniques. Different types of serologic tests are used to diagnose various disease conditions. Serologic tests have one thing in common. They all focus on proteins made by your immune system. This vital body system helps keep you healthy by destroying foreign invaders that can make you ill. The process for having the test is the same regardless of which technique the laboratory uses during serologic testing.

Antigens are substances that provoke a response from the immune system. They’re usually too small to see with the naked eye. They can enter the human body through the mouth, through broken skin, or through the nasal passages. Antigens that commonly affect people include bacteria, fungi, viruses and parasites. The immune system defends against antigens by producing antibodies. These antibodies are particles that attach to the antigens and deactivate them. When your doctor tests your blood, they can identify the type of antibodies and antigens that are in your blood sample, and identify the type of infection you have. Sometimes the body mistakes its own healthy tissue for outside invaders and produces unnecessary antibodies. This is known as an autoimmune disorder. Serologic testing can detect these antibodies and help your doctor diagnose an autoimmune disorder.

An antibody or serology test is a blood test that looks for signs of a previous COVID-19 infection. It detects antibodies, which are proteins in the blood that fight-off infection. Antibody testing has a lot of promise because it will help us understand the pervasiveness of COVID-19 in our communities. But, antibody testing shouldn’t be relied on for accurately predicting individual immunity. This means that even if you receive a positive antibody result, showing that COVID-19 antibodies were detected, you will not know with any certainty that you cannot get COVID-19 again. Everyone should continue to follow the recommendations on physical distancing and hygiene until scientists and doctors understand the disease better.

The care and treatment provided after serologic testing can vary. It often depends on whether antibodies were found. It may also depend on the nature of your immune response and its severity. An antibiotic or another type of medication may help your body fight the infection. Even if your results were normal, your doctor might order an additional test if they still think you might have an infection. The bacteria, virus, parasite, or fungus in your body will multiply over time. In response, your immune system will produce more antibodies. This makes the antibodies easier to detect as the infection gets worse. The test results may also show the presence of antibodies related to chronic conditions, such autoimmune disorders. Antibody tests are recommended as part of a clinical trial for health system workers and first responders.

On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.

Regards,

Robert Solomon

Editorial office

Journal of Clinical and Experimental Pathology

E-mail: pathol@eclinicalsci.com

Reach Us: +1-947-333-4405